Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate as Adjunct to Written Exposure Therapy for PTSD in Veterans
NCT07904000Phase 2Not yet recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Jul 2027
- Primary completion
- Sep 2030
- Countries
- 1
01
Overview
A Phase 2 trial of methylphenidate hydrochloride extended-release chewable tablet in post-traumatic stress disorder (PTSD), sponsored by VA Office of Research & Development. Planned start Jul 2027; status: not yet recruiting.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT07904000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07904000.